UBS Group AG - CONTEXT THERAPEUTICS INC ownership

CONTEXT THERAPEUTICS INC's ticker is and the CUSIP is 21077P108. A total of 22 filers reported holding CONTEXT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CONTEXT THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,241
+81.0%
5,767
+109.3%
0.00%
Q4 2022$1,791
-77.6%
2,755
-24.0%
0.00%
Q2 2022$8,0003,6270.00%
Other shareholders
CONTEXT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,143,745$745,3790.25%
Affinity Asset Advisors, LLC 883,654$583,6530.23%
swisspartners Ltd. 180,000$118,8960.15%
Worth Venture Partners, LLC 281,889$186,1880.11%
DIFESA CAPITAL MANAGEMENT, LP 34,878$22,7300.02%
Aspire Wealth Management Corp 10,000$6,5170.01%
Virtu Financial LLC 57,455$380.01%
Mill Creek Capital Advisors, LLC 104,631$68,1880.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 105,809$69,8870.00%
GEODE CAPITAL MANAGEMENT, LLC 61,202$400.00%
View complete list of CONTEXT THERAPEUTICS INC shareholders